Wealth Enhancement Trust Services »

Aardvark Therapeutics shares owned by Wealth Enhancement Trust Services

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Wealth Enhancement Trust Services from 13F filings

Historical chart of Wealth Enhancement Trust Services investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Wealth Enhancement Trust Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Wealth Enhancement Trust Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $276 48 5.75

More positions owned by Wealth Enhancement Trust Services

Two Rds Shared Tr Anfield Unvl Etf (AFIF)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ssga Active Etf Tr State Street Mul (RLY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Wisdomtree Tr Japn Hedge Eqt (DXJ)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Wealth Enhancement Trust Services

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Capital Management
AQR Capital Management
EcoR1 Capital
Adage Capital Partners GP
State Street Corporation
BlackRock
Geode Capital Management
Cantor Fitzgerald, L. P.
Two Sigma Investments
Raymond James Financial
Vanguard Fiduciary Trust
Woodline Partners

View all funds holding Aardvark Therapeutics